170 related articles for article (PubMed ID: 32763099)
1. Percutaneous closure of an atrial septal defect in a patient with Ebstein anomaly and right-to-left shunt.
Unzué L; García E; Solís J; Sánchez Recalde Á; Barceló JM; Parra J
Rev Port Cardiol (Engl Ed); 2020 Aug; 39(8):475.e1-475.e3. PubMed ID: 32763099
[TBL] [Abstract][Full Text] [Related]
2. AMPLATZER Septal Occluder failure resulting in paradoxical cerebral embolism.
Fernando RR; Koranne KP; Barker CM
Tex Heart Inst J; 2012; 39(5):647-52. PubMed ID: 23109759
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous closure of atrial right-to-left shunt in patients with Ebstein's anomaly of the tricuspid valve.
Silva M; Teixeira A; Menezes I; Nogueira G; Ferreira R; Maymone-Martins F; Anjos R
EuroIntervention; 2012 May; 8(1):94-7. PubMed ID: 22580253
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous Atrial Septal Defect Closure in Adult Ebstein's Anomaly with Exertional Hypoxemia.
Oka K; Seki M; Kataoka K; Sato T; Imai Y; Yamagata T
Int Heart J; 2020 May; 61(3):620-623. PubMed ID: 32418968
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of possible paradoxical embolic events in adults with ebstein anomaly and severe tricuspid regurgitation.
Attenhofer Jost CH; Connolly HM; Scott CG; Burkhart HM; Ammash NM; Dearani JA
Congenit Heart Dis; 2014; 9(1):30-7. PubMed ID: 23601093
[TBL] [Abstract][Full Text] [Related]
6. Amplatzer occluder versus CardioSEAL/STARFlex occluder: a meta-analysis of the efficacy and safety of transcatheter occlusion for patent foramen ovale and atrial septal defect.
Li Y; Zhou K; Hua Y; Wang C; Xie L; Fang J; Rong X; Shen J
Cardiol Young; 2013 Aug; 23(4):582-96. PubMed ID: 23199453
[TBL] [Abstract][Full Text] [Related]
7. Interventional closure of atrial septal defects in adult patients with Ebstein's anomaly.
Jategaonkar SR; Scholtz W; Horstkotte D; Kececioglu D; Haas NA
Congenit Heart Dis; 2011; 6(4):374-81. PubMed ID: 21435187
[TBL] [Abstract][Full Text] [Related]
8. Closure of a coexisting ostium secundum atrial septal defect and patent foramen ovale using a single Amplatzer patent foramen ovale occluder device.
Luna M; Banerjee S; Brilakis ES
Cardiovasc Revasc Med; 2010; 11(1):63-6. PubMed ID: 20129363
[TBL] [Abstract][Full Text] [Related]
9. Iatrogenic erosion of the septum primum resulting in an atrial septal defect with left-to-right shunt: a rare pitfall of patent foramen ovale percutaneous closure.
Scacciatella P; Biava LM; Marra S
Catheter Cardiovasc Interv; 2014 Sep; 84(3):494-6. PubMed ID: 24399577
[TBL] [Abstract][Full Text] [Related]
10. Defect closure in the lipomatous hypertrophied atrial septum with the Amplatzer muscular ventricular septal defect closure device: a case series.
Lin CH; Balzer DT; Lasala JM
Catheter Cardiovasc Interv; 2011 Jul; 78(1):102-7. PubMed ID: 21416575
[TBL] [Abstract][Full Text] [Related]
11. Should we close hypoxaemic patent foramen ovale and interatrial shunts on a systematic basis?
El Tahlawi M; Jop B; Bonello B; Dragulescu A; Rouault F; Habib G; Fraisse A
Arch Cardiovasc Dis; 2009 Nov; 102(11):755-9. PubMed ID: 19944391
[TBL] [Abstract][Full Text] [Related]
12. [A newborn with multiple cerebral infarction probably due to the right-to-left shunt associated with Ebstein's anomaly and atrial septal defect].
Yamamoto A; Yui T; Kobayashi K; Kawano Y; Hayashi M
No To Hattatsu; 2008 Jul; 40(4):334-6. PubMed ID: 18634422
[No Abstract] [Full Text] [Related]
13. Percutaneous Intervention to Treat Platypnea-Orthodeoxia Syndrome: The Toronto Experience.
Shah AH; Osten M; Leventhal A; Bach Y; Yoo D; Mansour D; Benson L; Wilson WM; Horlick E
JACC Cardiovasc Interv; 2016 Sep; 9(18):1928-38. PubMed ID: 27659570
[TBL] [Abstract][Full Text] [Related]
14. Transcatheter closure of a small atrial septal defect with an Amplatzer™ patent foramen ovale occluder in a working dog with cyanosis and exercise intolerance at high altitude.
Shelden A; Wesselowski S; Gordon SG; Saunders AB
J Vet Cardiol; 2017 Dec; 19(6):523-529. PubMed ID: 29111287
[TBL] [Abstract][Full Text] [Related]
15. Impact of occluder device type on success of percutaneous closure of atrial septal defects--a medium-term follow-up study.
Becker M; Frings D; Schröder J; Ocklenburg C; Mühler E; Hoffmann R; Franke A; Lepper W
J Interv Cardiol; 2009 Dec; 22(6):503-10. PubMed ID: 19821880
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous Closure of a Cribriform Secundum Atrial Septal Defect and Patent Foramen Ovale.
Wilson J; Oberoi M; Stys T; Stys A
S D Med; 2021 May; 74(5):227-229. PubMed ID: 34437781
[TBL] [Abstract][Full Text] [Related]
17. Bailout transcatheter closure of patent foramen ovale for refractory hypoxaemia after left ventricular assist device implantation.
Fischer Q; Kirsch M; Brochet E; Juliard JM
Interact Cardiovasc Thorac Surg; 2015 Aug; 21(2):246-8. PubMed ID: 25912477
[TBL] [Abstract][Full Text] [Related]
18. Rescue treatment by percutaneous closure of interatrial septal defect or PFO in infants with Berlin heart.
Gagliardi MG; Papavasileiou L; Pongiglione G
Catheter Cardiovasc Interv; 2011 Mar; 77(4):577-9. PubMed ID: 20853353
[TBL] [Abstract][Full Text] [Related]
19. Transcranial Doppler quantification of residual shunt after percutaneous patent foramen ovale closure. Comparison of two devices.
Sorensen SG; Aguilar H; McKnight WK; Thomas H; Muhlestein JB
J Interv Cardiol; 2010 Dec; 23(6):575-80. PubMed ID: 20796165
[TBL] [Abstract][Full Text] [Related]
20. Residual shunt after percutaneous closure of patent foramen ovale with AMPLATZER occluder devices - influence of anatomic features: a transcranial Doppler and intracardiac echocardiography study.
Marchese N; Pacilli MA; Inchingolo V; Fanelli R; Loperfido F; Vigna C
EuroIntervention; 2013 Jul; 9(3):382-8. PubMed ID: 23872652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
